APTYS PHARMACEUTICALS Revenue and Competitors
Estimated Revenue & Valuation
- APTYS PHARMACEUTICALS's estimated annual revenue is currently $3.6M per year.
- APTYS PHARMACEUTICALS's estimated revenue per employee is $201,000
Employee Data
- APTYS PHARMACEUTICALS has 18 Employees.
APTYS PHARMACEUTICALS's People
| Name | Title | Email/Phone |
|---|
APTYS PHARMACEUTICALS Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is APTYS PHARMACEUTICALS?
APTYS is a CRDO (contract research and development organization) which develops innovative products based of its expertise in pharmaceutical technologies and peptide delivery. APTYS offers ISO9001 aligned contract service, according to cGMP.  Custom-made formulation development including in vivo/in vitro assessments.  Semi solid dosage forms for topical and transdermal delivery.  Injectable peptide depot formulations.  Analytical development and validations.  Quality control and ICH stability.
keywords:N/A
N/A
Total Funding
18
Number of Employees
$3.6M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Saint-Beauzire
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $274.1M | 725 | 5% | N/A |
#2 | $3332.1M | 8815 | 6% | N/A |